Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-16

Study Completion Date

2028-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.

Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.

This study will assess the feasibility of oncoesthetics and describe any obstacles.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer

NCT01089803

Squamous Cell Carcinoma Laryngeal Cancer

COMPLETED

Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

NCT07000253

Esophageal Cancer Gastric (Stomach) Cancer Gastric Adenocarcinoma +3 more

NOT_YET_RECRUITING PHASE2/PHASE3

Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

NCT01348217

Esophageal Cancer

COMPLETED PHASE2/PHASE3

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

NCT00047112

Esophageal Cancer

COMPLETED PHASE3

Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract

NCT01361100

Carcinoma

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The majority of patients treated for VADS cancer come from disadvantaged socio-professional and family backgrounds. Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.

The French association for Oncological Support Care (SOS) defines socio-aesthetics as "the professional practice of aesthetic care adapted to people who are fragile or suffering as a result of an attack on their physical or psychological integrity, or in social distress". Priority patients for aesthetic care are those whose treatments have had an impact on body image (mutilating surgery, skin toxicities), and/or who are in a situation of social precariousness and suffer from a loss of self-esteem.

For patients suffering from VADS cancer, a population not usually in need of aesthetic care but in need of self-image restoration, an incentive program has been set up. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.

This study will assess the feasibility of OAS for VADS cancer patients, and describe any obstacles.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncology Aerodigestive Tract Cancer Suportive Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Three sessions of Adapted Onco-Esthetics

Patients will received three sessions of Adapted Onco-Esthetics

Group Type EXPERIMENTAL

Adapted Onco-Esthetics sessions

Intervention Type OTHER

Patient will received three sessions of Adapted Onco-Esthetics

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adapted Onco-Esthetics sessions

Patient will received three sessions of Adapted Onco-Esthetics

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 or over
* Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
* Patient due to start oncological treatment (recurrence authorized)
* Patient fluent in French.
* Affiliation with a social security scheme
* Signature of informed consent prior to any specific procedure linked to the study
* Treatment with curative intent

Exclusion Criteria

* Breast-feeding or pregnant patient
* Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
* Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
* Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No